Deeptech startup BioCompute is packing up and leaving India just months after launching in 2024. The company, which develops revolutionary DNA-based data storage technology, cited unfavorable regulatory conditions and limited infrastructure support for synthetic biology research as primary reasons for the move.
Founder and CEO explained that converting digital data into synthetic DNA sequences requires specialized laboratory facilities and regulatory approvals that are easier to obtain elsewhere. The ultra-dense storage technology can archive massive datasets in microscopic DNA strands, offering unprecedented energy efficiency compared to traditional data centers.
The relocation highlights India’s ongoing challenges in supporting cutting-edge biotechnology ventures. Despite the country’s growing startup ecosystem, deeptech companies working with synthetic biology continue to face regulatory hurdles that force them to seek more conducive environments for scaling their innovations.
Source: Read original article